Jump to content

CCL21

From Wikipedia, the free encyclopedia
CCL21
Available structures
PDBOrtholog search:PDBeRCSB
Identifiers
AliasesCCL21,6Ckine, CKb9, ECL, SCYA21, SLC, TCA4, C-C motif chemokine ligand 21
External IDsOMIM:602737;MGI:1349183;HomoloGene:2247;GeneCards:CCL21;OMA:CCL21 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_002989

NM_011124

RefSeq (protein)

NP_002980

NP_035254

Location (UCSC)Chr 9: 34.71 – 34.71 MbChr 4: 42.77 – 42.77 Mb
PubMedsearch[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Chemokine (C-C motif) ligand 21(CCL21) is a smallcytokinebelonging to the CCchemokinefamily. This chemokine is also known as 6Ckine (because it has six conservedcysteineresidues instead of the four cysteines typical to chemokines), exodus-2, and secondary lymphoid-tissue chemokine (SLC).[5][6][7]CCL21 elicits its effects by binding to a cell surfacechemokine receptorknown asCCR7.[8]The main function of CCL21 is to guideCCR7expressingleukocytesto thesecondary lymphoid organs,such aslymph nodesandPeyer´s patches.[9]

Gene[edit]

Thegenefor CCL21 is located on humanchromosome9.[10]CCL21 is classified as a homeostaticchemokine,it is produced constitutively. However, its expression increases duringinflammation.[9][11]

Protein structure[edit]

ChemokineCCL21 contains an extendedC-terminuswhich is not found inCCL19,another ligand ofCCR7.C-terminal tailis composed of 37amino acidsrich in positively charged residues and therefore, it has high affinity for negatively charged molecules of theextracellular matrix.The cleavage of theC-terminal tailby peptidases produces a soluble form of CCL21.[12]The soluble CCL21 occurs also inphysiological conditions.It does not bind toextracellular matrixand therefore, its function differs from the function of the full-length CCL21.[11]

Function[edit]

Migration to secondary lymphoid organs[edit]

Naïve T cellscirculate throughsecondary lymphoid organsuntil they encounter theantigen.[13]CCL21 is achemokineinvolved in the recruitment ofT cellsintosecondary lymphoid organs.It is produced by lymphatic endothelial cells andlymph node stromal cells.[7][12]Full-length CCL21 is bound toglycosaminoglycans,andendothelial cellsand it induces the chemotactic migration ofT cellsand thecell adhesioncaused byintegrinactivation.[9]In contrast, the soluble CCL21 is not involved in the induction of thecell adhesion.[11]AfterT cellsenter thelymph nodesthroughhigh endothelial venules,they are attracted to the T cell zone, where fibroblastic reticular cells are the abundant source of CCL21.[13][9]

CCL21/CCR7interaction also plays a role in the migration ofdendritic cellsto thesecondary lymphoid organs.[14][11][9]Dendritic cellsupregulate the expression ofCCR7during their maturation.[14]CCL21 is bound to thelymphatic vesselsand attractsCCR7expressingdendritic cellsfrom peripheral tissues. Then they migrate along the chemokine gradient to thelymph nodewhere theypresent the antigentoT cells.[9]Interactions betweendendritic cellsandT cellsare necessary for the initiation of theadaptive immune response.[15]When CCL21 is not recognized by the cells (for example inCCR7-deficient mice), a delayed and reducedadaptive immune responseoccurs due to reduced interactions betweendendritic cellsandT cellsin thelymph nodes.[9]Semi-maturedendritic cellsexpressCCR7in the absence of a danger signal. They use CCL21 chemokine gradient for the migration to thelymph nodeseven when there is noinflammationin the body, and they contribute toperipheral tolerance.[11]

Othercellsusing chemokine CCL21 for the migration to thelymph nodesareB cells.However, they are less dependent on it in comparison toT cells.[9]

T cell development in the thymus[edit]

CCL21/CCR7interaction plays a role in theT celldevelopment in thethymus.CCL21 is produced in the thymus medulla bymedullary thymic epithelial cells,and it attracts single positivethymocytesfrom the thymus cortex to the medulla, where they undergonegative selectionto delete autoreactivethymocytes.[9]

References[edit]

  1. ^abcGRCh38: Ensembl release 89: ENSG00000137077Ensembl,May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000094686Ensembl,May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Hedrick JA, Zlotnik A (August 1997)."Identification and characterization of a novel beta chemokine containing six conserved cysteines".Journal of Immunology.159(4): 1589–1593.doi:10.4049/jimmunol.159.4.1589.PMID9257816.S2CID23429282.
  6. ^Hromas R, Kim CH, Klemsz M, Krathwohl M, Fife K, Cooper S, et al. (September 1997)."Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension".Journal of Immunology.159(6): 2554–2558.doi:10.4049/jimmunol.159.6.2554.PMID9300671.S2CID33971251.
  7. ^abNagira M, Imai T, Hieshima K, Kusuda J, Ridanpää M, Takagi S, et al. (August 1997)."Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13".The Journal of Biological Chemistry.272(31): 19518–19524.doi:10.1074/jbc.272.31.19518.PMID9235955.
  8. ^Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O (March 1998)."Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7".The Journal of Biological Chemistry.273(12): 7118–7122.doi:10.1074/jbc.273.12.7118.PMID9507024.
  9. ^abcdefghiComerford I, Harata-Lee Y, Bunting MD, Gregor C, Kara EE, McColl SR (June 2013). "A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system".Cytokine & Growth Factor Reviews.24(3): 269–283.doi:10.1016/j.cytogfr.2013.03.001.PMID23587803.
  10. ^Blanchet X, Langer M, Weber C, Koenen RR, von Hundelshausen P (July 2012)."Touch of chemokines".Frontiers in Immunology.3:175.doi:10.3389/fimmu.2012.00175.PMC3394994.PMID22807925.
  11. ^abcdeHauser MA, Legler DF (June 2016)."Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes".Journal of Leukocyte Biology.99(6): 869–882.doi:10.1189/jlb.2MR0815-380R.PMID26729814.S2CID5005741.
  12. ^abJørgensen AS, Rosenkilde MM, Hjortø GM (March 2018). "Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective".General and Comparative Endocrinology.258:4–14.doi:10.1016/j.ygcen.2017.07.004.PMID28694053.
  13. ^abHunter MC, Teijeira A, Halin C (December 2016)."T Cell Trafficking through Lymphatic Vessels".Frontiers in Immunology.7:613.doi:10.3389/fimmu.2016.00613.PMC5174098.PMID28066423.
  14. ^abFörster R, Davalos-Misslitz AC, Rot A (May 2008). "CCR7 and its ligands: balancing immunity and tolerance".Nature Reviews. Immunology.8(5): 362–371.doi:10.1038/nri2297.PMID18379575.S2CID19725359.
  15. ^Bousso P (September 2008). "T-cell activation by dendritic cells in the lymph node: lessons from the movies".Nature Reviews. Immunology.8(9): 675–684.doi:10.1038/nri2379.PMID19172690.S2CID6551798.

External links[edit]

Further reading[edit]